Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells
Anticancer Research · 2024
DOI: 10.21873/anticanres.16987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Byung Chul Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A. Hauptthemen laut MEDLINE: Anoikis, Gefitinib, Ubiquitin-Protein Ligases, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A.
- Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea.
- Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea; sunghoonkim@kornu.ac.kr.
- Department of Biomedical Laboratory Science, Korea Nazarene University, Cheonan, Republic of Korea.
- Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea; yoonsukkim@yonsei.ac.kr.
Zitieren
APA
Jung, B. C., Woo, S. H., Kim, S. H., & Kim, Y. S. (2024). Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16987
Vancouver
Jung BC, Woo SH, Kim SH, Kim YS. Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells. Anticancer Research. 2024. doi:10.21873/anticanres.16987
BibTeX
@article{Jung2024,
author = {Jung, Byung Chul and Woo, Sung-Hun and Kim, Sung Hoon and Kim, Yoon Suk},
title = {Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16987}
}
EUVIMED